Breast Mesh Manufacturers: Who Made These Products and What Lawsuits Allege

When a medical device causes harm, the question of who is responsible starts with who made it. Several companies manufacture the surgical mesh products used in breast reconstruction and augmentation. Lawsuits against these manufacturers allege that they knew about risks, failed to adequately test their products, and prioritized profits over patient safety. Here is what you should know about the companies involved and what the litigation claims.

The Companies Behind Breast Mesh Products

Surgical mesh used in breast procedures comes from a handful of medical device manufacturers. Some of these are large, well-known corporations. Others are smaller companies that specialize in surgical products. Understanding which company made your mesh is the first step in determining your legal options.

Galatea Surgical (Tepha, Inc.)

Galatea Surgical manufactures GalaFLEX, a bioresorbable mesh made from poly-4-hydroxybutyrate (P4HB). GalaFLEX was marketed as a next-generation alternative to traditional mesh, designed to provide temporary support and then be absorbed by the body over approximately 18 months. It received FDA 510(k) clearance — a process that allows devices to reach the market based on similarity to existing products rather than through independent clinical trials.

Patients have reported complications including capsular contracture, chronic pain, seroma formation, and inflammatory reactions. Some patients allege that the mesh degraded unpredictably, either too quickly or incompletely, leading to complications that were not anticipated based on marketing claims.

Novus Scientific

Novus Scientific developed the TIGR Matrix, a long-term bioresorbable mesh made from a blend of two synthetic fibers designed to be absorbed at different rates. The product was intended to provide support during healing and then gradually disappear. Like GalaFLEX, TIGR Matrix was cleared through the 510(k) pathway.

Reported complications with TIGR Matrix include similar patterns: capsular contracture, pain, infection, and inadequate tissue support as the mesh is absorbed. Some patients found that the mesh broke down before their tissue had healed sufficiently to maintain the surgical result, leading to implant malposition or failure.

Ethicon (Johnson & Johnson)

Ethicon, a subsidiary of Johnson & Johnson, manufactures several mesh products including Vicryl mesh and Prolene mesh. While these products are more commonly associated with hernia repair litigation, they have also been used in breast surgery. Ethicon is no stranger to mesh litigation — the company has faced thousands of lawsuits related to its pelvic mesh products, resulting in billions of dollars in settlements.

Other Manufacturers

Several other companies produce mesh products that have been used in breast surgery, including C.R. Bard (now part of BD - Becton Dickinson), Atrium Medical, and various manufacturers of acellular dermal matrix (ADM) products like AlloDerm (Allergan/AbbVie) and FlexHD (Ethicon). The specific manufacturer matters because each company's products have different compositions, different clearance histories, and different safety profiles.

What the Lawsuits Allege

Breast mesh lawsuits make several types of claims against manufacturers. While the specific allegations vary by product and case, common legal theories include the following.

Design Defect

Plaintiffs allege that the mesh products were inherently dangerous due to their design. This can mean that the material itself causes excessive inflammation, that the mesh structure promotes bacterial colonization, or that the product degrades in ways that cause tissue damage. A design defect claim argues that even when manufactured correctly and used as intended, the product poses unreasonable risks.

Failure to Warn

These claims allege that manufacturers knew or should have known about specific risks but did not adequately communicate them to surgeons or patients. If a company had data showing elevated rates of capsular contracture, chronic pain, or other complications — but did not include clear warnings in product labeling or surgical instructions — patients and their doctors were denied the information they needed to make informed decisions.

Failure to warn claims are particularly significant when a product reaches the market through the 510(k) pathway. Because 510(k) clearance does not require the same level of clinical testing as premarket approval (PMA), there may be gaps in the safety data available at the time of clearance. If complications only become apparent after widespread use, and the manufacturer fails to update warnings, that delay can form the basis of a legal claim.

Negligent Marketing

Some lawsuits allege that manufacturers promoted their mesh products with misleading claims about safety and effectiveness. This includes marketing to surgeons through sales representatives, conference presentations, and promotional materials that overstated benefits and minimized risks. If a company marketed its mesh as having a low complication rate without adequate clinical evidence to support that claim, affected patients may have been harmed by the misrepresentation.

Manufacturing Defect

In some cases, lawsuits allege that specific batches or lots of mesh were manufactured improperly — contaminated, improperly sterilized, or produced with materials that did not meet specifications. Manufacturing defect claims are typically product-specific and may be supported by FDA inspection reports, recall notices, or adverse event data linked to particular lot numbers.

The FDA 510(k) Clearance Problem

A recurring theme in breast mesh litigation is the FDA's 510(k) clearance process. Under 510(k), a medical device can be cleared for sale if the manufacturer demonstrates that it is "substantially equivalent" to a device already on the market — called a predicate device. This process does not require the kind of rigorous clinical trials that new drugs must undergo.

Critics of the 510(k) pathway argue that it allows devices with limited safety data to reach patients. In the case of breast mesh, some products were cleared based on their similarity to mesh products designed for hernia repair or other applications. Whether those predicate devices were truly comparable — in terms of the tissue environment, the forces involved, and the patient population — is a question at the heart of many lawsuits.

The FDA has faced growing pressure to reform the 510(k) process, particularly after high-profile failures involving surgical mesh, metal-on-metal hip implants, and other devices. For patients who were harmed by a product that entered the market through 510(k), the clearance process itself can be evidence that adequate safety testing was never performed.

How Accountability Is Being Pursued

Breast mesh patients are pursuing accountability through several legal channels:

• Individual lawsuits: Filed in state or federal court, these cases allow patients to present their specific injuries and seek compensation for medical costs, pain and suffering, lost wages, and other damages.
• Multidistrict litigation (MDL): When many similar cases are filed in federal court, they may be consolidated into an MDL for pretrial proceedings. This streamlines the process by allowing common issues — like whether a product was defective — to be addressed once rather than in hundreds of separate cases.
• Class actions: In some cases, patients may pursue class action claims, particularly for consumer protection violations or misleading marketing.
• FDA reporting: Adverse event reports submitted to the FDA through the MedWatch program contribute to the body of evidence about a product's safety. While not a legal claim, these reports can trigger regulatory action like safety warnings, label changes, or product recalls.

What This Means for You

If you had a breast mesh implant and experienced complications, knowing which manufacturer made your product is the first step toward understanding your legal options. Your operative report — available from your surgeon or the hospital — will identify the specific product and manufacturer.

You do not need to prove your case on your own. Legal teams that handle medical device litigation work with medical experts, engineers, and regulatory specialists to build cases against manufacturers. A free case evaluation can help you determine whether the complications you experienced may be linked to a defective product and what your next steps should be.

Manufacturers have teams of lawyers working to protect their interests. Patients deserve experienced advocates working to protect theirs. If you believe your breast mesh caused you harm, taking that first step toward a case evaluation puts you on equal footing.